共 23 条
[1]
Henneman M.M., Bengel F.M., Van Der Wall E.E., Knuuti J., Bax J.J., Cardiac neuronal imaging: Application in the evaluation of cardiac disease, J Nucl Cardiol, 15, pp. 442-455, (2008)
[2]
Merlet P., Benvenuti C., Moyse D., Pouillart F., Dubois-Rande J.-L., Duval A.-M., Loisance D., Castaigne A., Syrota A., Prognostic value of MIBG imaging in idiopathic dilated cardiomyopathy, Journal of Nuclear Medicine, 40, 6, pp. 917-923, (1999)
[3]
Fujimoto S., Inoue A., Hisatake S., Yamashina S., Yamashina H., Nakano H., Yamazaki J., Usefulness of <sup>123</sup>I-metaiodobenzylguanidine myocardial scintigraphy for predicting the effectiveness of β-blockers in patients with dilated cardiomyopathy from the standpoint of long-term prognosis, European Journal of Nuclear Medicine and Molecular Imaging, 31, 10, pp. 1356-1361, (2004)
[4]
Nakata T., Wakabayashi T., Kyuma M., Takahashi T., Tsuchihashi K., Shimamoto K., Cardiac metaiodobenzylguanidine activity can predict the long-term efficacy of angiotensin-converting enzyme inhibitors and/or beta-adrenoceptor blockers in patients with heart failure, European Journal of Nuclear Medicine and Molecular Imaging, 32, 2, pp. 186-194, (2005)
[5]
Anastasiou-Nana M.I., Terrovitis J.V., Athanasoulis T., Karaloizos L., Geramoutsos A., Pappa L., Tsagalou E.P., Efentakis S., Nanas J.N., Prognostic value of iodine-123-metaiodobenzylguanidine myocardial uptake and heart rate variability in chronic congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy, American Journal of Cardiology, 96, 3, pp. 427-431, (2005)
[6]
Arimoto T., Takeishi Y., Niizeki T., Nozaki N., Hirono O., Watanabe T., Nitobe J., Tsunoda Y., Suzuki S., Koyama Y., Kitahara T., Okada A., Takahashi K., Kubota I., Cardiac sympathetic denervation and ongoing myocardial damage for prognosis in early stages of heart failure, Journal of Cardiac Failure, 13, 1, pp. 34-41, (2007)
[7]
Kioka H., Yamada T., Mine T., Morita T., Tsukamoto Y., Tamaki S., Masuda M., Okuda K., Hori M., Fukunami M., Prediction of sudden death in patients with mild-to-moderate chronic heart failure by using cardiac iodine-123 metaiodobenzylguanidine imaging, Heart, 93, 10, pp. 1213-1218, (2007)
[8]
Kasama S., Toyama T., Kumakura H., Takayama Y., Ichikawa S., Suzuki T., Kurabayashi M., Effect of spironolactone on cardiac sympathetic nerve activity and left ventricular remodeling in patients with dilated cardiomyopathy, Journal of the American College of Cardiology, 41, 4, pp. 574-581, (2003)
[9]
Kasama S., Toyama T., Hatori T., Sumino H., Kumakura H., Takayama Y., Ichikawa S., Suzuki T., Kurabayashi M., Evaluation of cardiac sympathetic nerve activity and left ventricular remodelling in patients with dilated cardiomyopathy on the treatment containing carvedilol, European Heart Journal, 28, 8, pp. 989-995, (2007)
[10]
Kakuchi H., Sasaki T., Ishida Y., Komamura K., Miyatake K., Clinical usefulness of <sup>123</sup>I meta-iodobenzylguanidine imaging in predicting the effectiveness of β blockers for patients with idiopathic dilated cardiomyopathy before and soon after treatment, Heart, 81, 2, pp. 148-152, (1999)